生物技术与制药领域的最新动态
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies - PR Newswire
Nuclera and Danaher-owned US ally boost protein proposition - Business Weekly
Waters Corporation Announces Acquisition of Halo Labs - Spectroscopy Online
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents - GEN - Genetic Engineering and Biotechnology News
Lonza chooses TRU Global Solutions for cleanroom services - Cleanroom Technology
10x Eliminates 8% of Workforce in $50M Cost-Cutting Effort - GEN - Genetic Engineering and Biotechnology News
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer - Contract Pharma
10x Genomics and Bruker settle landmark UPC dispute - JUVE Patent
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - PR Newswire
Comparative analysis of Illumina, PacBio, and nanopore for 16S rRNA gene sequencing of rabbit’s gut microbiota - Frontiers
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub - PR Newswire
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
SEC ends probe of Illumina’s Grail acquisition - MedTech Dive
10x Genomics Reports First Quarter 2025 Financial Results - PR Newswire
Improving CGT Production to Speed Delivery and Lower Cost - GEN - Genetic Engineering and Biotechnology News
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers - GEN - Genetic Engineering and Biotechnology News
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
Waters Corporation (NYSE:WAT) Posts Better-Than-Expected Sales In Q1, Next Quarter’s Sales Guidance is Optimistic - Yahoo Finance
Waters Announces Update to its Empower Software to Support Biologics Data Acquisition - Spectroscopy Online